bluebird bio

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch bluebird bio and buy or sell other stocks, ETFs, and their options commission-free!

About BLUE

bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases. It also offers ZYNTEGLO or beti-cel and SKYSONA or eli-cel gene therapies. 

CEO
David D. Meek
CEODavid D. Meek
Employees
248
Employees248
Headquarters
Somerville, Massachusetts
HeadquartersSomerville, Massachusetts
Founded
1992
Founded1992
Employees
248
Employees248

BLUE Key Statistics

Market cap
48.66M
Market cap48.66M
Price-Earnings ratio
-0.24
Price-Earnings ratio-0.24
Dividend yield
Dividend yield
Average volume
193.95K
Average volume193.95K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$28.60
52 Week high$28.60
52 Week low
$3.20
52 Week low$3.20

People also own

Based on the portfolios of people who own BLUE. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.